Literature DB >> 2752164

Prevention of chronic ITP?

B U Müller1, P Imbach.   

Abstract

The treatment of childhood ITP with IVIG has been widely used in acute or in previously treatment-dependent, chronic forms of the disease. We discuss propositions of a prospective multicenter study to evaluate the efficacy of IVIG to prevent the development of chronic ITP in childhood. The problems of such a study, i.e. evaluation criteria, number (about 10% of patients with acute ITP will develop the chronic form) and related topics are discussed.

Entities:  

Mesh：

Year:  1989        PMID： 2752164     DOI： 10.1007/bf00320259

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


  3 in total

1.  Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.

Authors:  P Imbach; H P Wagner; W Berchtold; G Gaedicke; A Hirt; P Joller; C Mueller-Eckhardt; B Müller; E Rossi; S Barandun
Journal:  Lancet       Date:  1985-08-31       Impact factor: 79.321

2.  Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: a prospective multicenter study.

Authors:  B Imholz; P Imbach; C Baumgartner; W Berchtold; G Gaedicke; E Gugler; A Hirt; W Hitzig; C Mueller-Eckhardt; H P Wagner
Journal:  Blut       Date:  1988-02

3.  Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy.

Authors:  J B Bussel; I Schulman; M W Hilgartner; S Barandun
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406
  3 in total
  1 in total

1.  Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.

Authors:  Muhittin Celik; Ali Bulbul; Gönül Aydogan; Deniz Tugcu; Emrah Can; Sinan Uslu; Mesut Dursun
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.